EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome

Hong Zhu, Yi Wang, Ge Wang, Yitong Ling, Jinhai Tian, Yan Zhou, Rong Zhu, Rui Wang, Ruixin Wang, Wenhui Zhang, Xiaoyu Zhang

Clinical Rheumatology · 2024

DOI: 10.1007/s10067-024-06999-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Hong Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, RNA, Circular, Biomarkers, Leukocytes, Mononuclear. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Ningxia Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circular RNAs (circRNAs) play various roles in the development of many autoimmune diseases. However, their expression profiles and specific function in Sjögren's Syndrome remains largely unknown.

Objectives

We aimed to investigate circRNAs potential diagnostic value in primary Sjögren's syndrome (pSS) and contribution to the pathogenesis of pSS.

Methods

This study included 102 subjects, 51 pSS patients and 51 healthy controls. The concentration of hsa_circ_0045800 was analyzed in peripheral blood mononuclear cells obtained from 51 pSS patients and 51 healthy controls by qRT-PCR. We established a receiver operating characteristic curve (ROC) to assess the biological diagnostic value of hsa_circ_0045800 for pSS. In addition, we analyzed the correlation between hsa_circ_0045800 and disease activity in Sjogren's syndrome. A differential analysis was also conducted on the concentration of hsa_circ_0045800 in patients in pSS patients before and after treatment. We studied the downstream mechanism of hsa_circ_0045800 through bioinformatics analysis and confirmed it using luciferase reporter gene assay.

Results

We confirmed that the concentration of hsa_circ_0045800 was elevated 10.4-fold in peripheral blood mononuclear cells of pSS patients than in healthy controls (p = 0.00). In the pSS active disease group, the concentration of hsa_circ_0045800 is 2.5-fold higher compared to the pSS non-active disease group (p = 0.04). The concentration of hsa_circ_0045800 after treatment was decreased by 80% compared with that before treatment (p = 0.037), suggesting its utility as a potential marker for monitoring treatment efficacy. ROC curve analysis showed that the diagnostic value of hsa_circ_0045800 in pSS patients was significantly higher than that in healthy controls, with an area under the curve of 0.865, a sensitivity of 74%, and a specificity of 92%. The concentration of hsa_circ_0045800 is correlated with various clinical factors: the concentration of hsa_circ_0045800 is positively associated with age (r = 0.328, P = 0.019), oral dryness (r = 0.331, P = 0.017), while it is negatively correlated with HGB (r = -0.435, P = 0.001) and and hypothyroidism (r = -0.318, P = 0.023). Bioinformatics predictions and luciferase assays indicated that hsa_circ_0045800 acts as a molecular sponge for miR-1247-5p, with SMAD2 being a target gene of miR-1247-5p.

Conclusion

Our study results show that hsa_circ_0045800 potentially contributes to the development and progression of pSS via the miR-1247-5p/SMAD2 pathway. Peripheral blood mononuclear cells are directly involved in the pathogenesis of pSS, and the discovery of hsa_circ_0045800 in peripheral blood mononuclear cells highlights its potential as a novel biomarker for disease activity and diagnosis in patients with pSS. Key Points • The concentration of hsa_circ_0045800 was higher in peripheral blood mononuclear cells of pSS patients. • Hsa_circ_0045800 promoted pSS progression through miR-1247-5p–SMAD2 axis. • Hsa_circ_0045800 is a potential biomarker for pSS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeRNA, CircularBiomarkersLeukocytes, MononuclearHumansFemaleMaleMiddle AgedCase-Control StudiesAdultROC Curve

Stichwörter der Autor:innen

Hsa_circ_0045800Primary Sjögren’s syndromeSMAD2miR-1247-5p

Substanzen

RNA, CircularBiomarkers

Autor:innen und Institutionen

  • Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China.
  • The Second Department of Internal Medicine, Ningxia Gem Flower Hospital, Yinchuan 750006, Ningxia, China.
  • University of Health and Rehabilitation Sciences, Qingdao Municipal Hospital Group, Qingdao 266000, Shandong, China.
  • Department of Neurology, Jinan University First Afliated Hospital, Guangzhou 510000, Guangdong, China.
  • Biochip Center, General Hospital of Ningxia Medical University, Yinchuan 750004, Ningxia, China.
  • First Clinical Medical College of Ningxia Medical University, Yinchuan 750004, Ningxia, China.

Förderung

  • Natural Science Foundation of Ningxia Province

Zitieren

APA

Zhu, H., Wang, Y., Wang, G., Ling, Y., Tian, J., Zhou, Y., Zhu, R., Wang, R., Wang, R., Zhang, W., & Zhang, X. (2024). The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-06999-0

Vancouver

Zhu H, Wang Y, Wang G, Ling Y, Tian J, Zhou Y, et al. The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-06999-0

BibTeX
@article{Zhu2024,
  author = {Zhu, Hong and Wang, Yi and Wang, Ge and Ling, Yitong and Tian, Jinhai and Zhou, Yan and Zhu, Rong and Wang, Rui and Wang, Ruixin and Zhang, Wenhui and Zhang, Xiaoyu},
  title = {The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome},
  journal = {Clinical Rheumatology},
  year = {2024},
  doi = {10.1007/s10067-024-06999-0}
}
Kostenlos starten →